JP Morgan Upgrades iQIYI to Overweight, Raises Price Target to $8
JP Morgan analyst Alex Yao upgrades iQIYI (NASDAQ:IQ) from Underweight to Overweight and raises the price target from $2 to $8.
JD, Nio, Pinduoduo Among 80 Chinese Companies Identified By SEC For Potential Delisting: What Investors Should Know
The SEC continued to crack the regulatory whip on U.S.-listed Chinese companies for non-compliance with audit requirements necessitated by the "Holding Foreign Companies Accountable Act."
70 Biggest Movers From Friday
Gainers
GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners.
48 Stocks Moving In Friday’s Mid-Day Session
Gainers
Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS.
All The Stocks Bill Hwang’s Archegos Capital Is Accused Of Manipulating
From March 2020 through its collapse in March 2021, Archegos Capital Management, headed by Sung Kook (Bill) Hwang and partners, entered into a manipulative scheme that increased Archego’s bottom line from around $4 billion to $36 billion, according to a SEC lawsui
60 Biggest Movers From Yesterday
Gainers
Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
30 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Swvl Holdings Corp. (NASDAQ: SWVL) shares gained 34.3% to $5.72.
Alpha Tau Medical Ltd. (NASDAQ: DRTS) shares climbed 19.3% to $10.62.
53 Biggest Movers From Yesterday
Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
Are Investors Bullish On Chinese Stocks Again?
A raft of regulations targeting a number of sectors — from technology to real estate and education — have hammered Chinese stocks late last year and into 2022, and although many economists remain bullish on Chinese stocks’ potential, Beijing’s relationship with the Kremlin is now weighing on investor appetite for Chinese shares.